Dr. ZHANG
Dr. ZHANG Ruijun (張瑞君)
Dr. ZHANG Ruijun (張瑞君), aged 65, joined our Group as
an independent Director in July 2024, and was
re-designated as an independent non-executive Director
in June 2025, with effect from the Listing Date. She is
primarily responsible for supervising and providing
independent opinion and judgment to the
Board..HK)自立非制定副股东长局,2026年-9月起任济南天智航治疗高新科技持股现有大机构(新股码是什么:688277.SH)自立副股东长局,2025年7月起任招商代理证券业持股现有大机构(新股码是什么:600999.SH)自立副股东长局。1992年16月至2023年17月相继任国内 百姓一本大学副教导、教导。
Dr. Zhang has nearly 35 years of professional experience
in investment and financial management. She has been
serving as a partner and the chief executive officer in
Yarui Heyi Capital Management (Beijing) Co., Ltd.
(雅瑞和宜資本工作管理(成都)非常比较有限的企业責任企业) since July 2015.
Additionally, she has been holding independent
directorships in multiple listed companies, including
(i) an independent (non-executive) Director in China
Merchants Securities Co., Ltd. (的招商證券股分非常比较有限的企业企业),
the shares of which are listed on the Shanghai Stock
Exchange (stock code: 600999) and Stock Exchange (stock
code: 6099), since January 2024; (ii) an independent
Director in Beijing Tianzhihang Medical Technology Co.,
Ltd. (成都天智航醫療信息技术股分非常比较有限的企业企业), the shares of
which are listed on the Shanghai Stock Exchange (stock
code: 688277), since September 2023; (iii) an
independent non-executive Director in Inspur Digital
Enterprise Technology Co., Ltd.
(变革數字企業技術非常比较有限的企业企业), the shares of which are
listed on the Hong Kong Stock Exchange (stock code:
00596) since April 2014. From December 1992 to November
2022, Dr. Zhang worked at Renmin University of China
(中國市民大學), with her last role as a professor.
Dr. Zhang obtained her Ph.D. degree in accounting from
Renmin University of China (中國公民大學) in July 2002.
She also obtained her Certified Public Accountant (CPA)
qualification in the PRC in July 2015.